All In Biotech

Drug Trial Radar · NCT07218146

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody-Drug Conjugate (ADC), Compared to Investigator's Choice Therapy in Participants With Relapsed Small Cell Lung Cancer

Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 480 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

480

Planned (sponsor's estimate)

Start

Nov 30, 2025

Primary completion

Jun 30, 2028

Study completion Nov 30, 2028

Sponsor

Lead sponsor
Zai Lab (Shanghai) Co., Ltd.Industry
Sponsor type
Industry
Collaborators
Zai Lab (US) LLC
First posted
Oct 20, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung Cancer.

Conditions

  • Small-cell Lung Cancer

Interventions

  • ZL-1310Drug

    ZL-1310 as a single-agent

  • Investigator's Choice of TherapyDrug

    Topotecan or Amrubicin

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Confirmed objective response rate (ORR) assessed by Blinded Independent Central Review of ZL-1310 compared to Investigator's Choice Therapy (ICT)Time frame: up to 30 months
  2. Overall survival of ZL-1310 compared to Investigator's Choice Therapy (ICT)Time frame: up to 30 months

Locations

165 sites in 15 countries. Site status is shown where the registry gives one.

  • University of California San Diego

    La Jolla, California · Recruiting

  • UC Davis Comprehensive Cancer Center

    Sacramento, California · Recruiting

  • University of Colorado

    Aurora, Colorado · Recruiting

  • Yale Cancer Center/Clinical Trials Office

    New Haven, Connecticut · Recruiting

  • Clermont Oncology Center

    Clermont, Florida · Recruiting

  • Mid Florida Hematology and Oncology Center

    Orange City, Florida · Recruiting

  • Cancer Centers of Bevard

    Rockledge, Florida · Recruiting

  • Sarah Cannon Research Institute

    Sarasota, Florida · Recruiting

  • Florida Cancer Specialists - North

    St. Petersburg, Florida · Recruiting

  • Moffitt Cancer Center

    Tampa, Florida · Recruiting

  • Florida Cancer Specialists - East

    West Palm Beach, Florida · Recruiting

  • Illinois Cancer Care

    Peoria, Illinois · Recruiting

  • OSF St. Francis Medical Center

    Peoria, Illinois · Recruiting

  • University of Iowa

    Iowa City, Iowa · Recruiting

  • University of Iowa Mission Health Cancer + Blood

    Waukee, Iowa · Recruiting

  • Norton Cancer Institute

    Louisville, Kentucky · Recruiting

  • American Oncology Partners, PA - The Center for Cancer and Blood Disorders

    Bethesda, Maryland · Recruiting

  • Maryland Oncology Hematology

    Silver Spring, Maryland · Recruiting

  • Henry Ford Health Cancer

    Detroit, Michigan · Recruiting

  • Missouri Cancer Associates

    Columbia, Missouri · Recruiting

  • Mercy South

    St Louis, Missouri · Recruiting

  • Stony Brook Cancer Center

    Stony Brook, New York · Recruiting

  • Montefiore Medical Center

    The Bronx, New York · Recruiting

  • Cleveland Clinic - Akron General Medical Center

    Akron, Ohio · Recruiting

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio · Recruiting

  • Cleveland Clinic - Fairview Hospital Molly Pavilion

    Cleveland, Ohio · Recruiting

  • Cleveland Clinic

    Cleveland, Ohio · Recruiting

  • Cleveland Clinic - Hillcrest Hospital Cancer Center

    Mayfield Heights, Ohio · Recruiting

  • Consultants in Medical Oncology and Hematology

    Broomall, Pennsylvania · Recruiting

  • Alliance Cancer Specialists

    Media, Pennsylvania · Recruiting

  • Allegheny General Hospital

    Pittsburgh, Pennsylvania · Recruiting

  • University of Pittsburgh (UPMC) Hillman Cancer Center

    Pittsburgh, Pennsylvania · Recruiting

  • SCRI OP (Oncology Partners)

    Nashville, Tennessee · Recruiting

  • Texas Oncology - Central South

    Austin, Texas · Recruiting

  • University of Texas Southwestern Medical Center/Clinical Research Department

    Dallas, Texas · Recruiting

  • Texas Oncology - West Texas

    Odessa, Texas · Recruiting

  • Virginia Cancer Specialists

    Fairfax, Virginia · Recruiting

  • Uniklinikum Salzburg, Landeskrankenhaus, Universitatsklinik fur Innere Medizin III der PMU Department of Internal Medicine III

    Salzburg, Austria · Recruiting

  • Medizinische Universitaet Wien - Allgemeines Krankenhaus der Stadt Wien (AKH)

    Vienna, Austria · Recruiting

  • Universitair Ziekenhuis Antwerpen

    Edegem, Belgium · Recruiting

Showing 40 of 165 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.